Anbio Biotechnology — Investor Relations & Filings

Anbio Biotechnology is a medical device company specializing in the development and provision of in-vitro diagnostic (IVD) solutions. The company's portfolio includes a diverse range of diagnostic instruments and assays for laboratory, point-of-care (POCT), and over-the-counter (OTC) applications. Its products are designed to detect biomarkers across numerous medical fields, such as infectious diseases, cancer, cardiovascular diseases, inflammation, and endocrine disorders. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company focuses on advancing medical technology by creating personalized and decentralized diagnostic tools to enhance patient care and outcomes globally.